Search

Your search keyword '"Kamp, Otto"' showing total 786 results
Start Over Author "Kamp, Otto"
786 results on '"Kamp, Otto"'

54. Non-invasive imaging in coronary syndromes: recommendations of the European Association of Cardiovascular Imaging and the American Society of Echocardiography, in collaboration with the American Society of Nuclear Cardiology, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance

Author

Edvardsen, Thor, primary, Asch, Federico M, additional, Davidson, Brian, additional, Delgado, Victoria, additional, DeMaria, Anthony, additional, Dilsizian, Vasken, additional, Gaemperli, Oliver, additional, Garcia, Mario J, additional, Kamp, Otto, additional, Lee, Daniel C, additional, Neglia, Danilo, additional, Neskovic, Aleksandar N, additional, Pellikka, Patricia A, additional, Plein, Sven, additional, Sechtem, Udo, additional, Shea, Elaine, additional, Sicari, Rosa, additional, Villines, Todd C, additional, Lindner, Jonathan R, additional, and Popescu, Bogdan A, additional

Published
2021
Full Text
View/download PDF

57. Mobile health adherence for the detection of recurrent recent-onset atrial fibrillation.

Author

van der Velden, Rachel M. J., Pluymaekers, Nikki A. H. A., Dudink, Elton A. M. P., Luermans, Justin G. L. M., Meeder, Joan G., Heesen, Wilfred F., Lenderink, Timo, Widdershoven, Jos W. M. G., Bucx, Jeroen J. J., Rienstra, Michiel, Kamp, Otto, van Opstal, Jurren M., Kirchhof, Charles J. H. J., van Dijk, Vincent F., Swart, Henk P., Alings, Marco, Van Gelder, Isabelle C., Crijns, Harry J. G. M., and Linz, Dominik

Subjects
ATRIAL fibrillation, MOBILE health, PATIENT compliance, OLDER patients, HEART beat, ELECTRICAL injuries
Abstract

Objective: The Rate Control versus Electrical Cardioversion Trial 7-Acute Cardioversion versus Wait and See trial compared early to delayed cardioversion for patients with recent-onset symptomatic atrial fibrillation (AF). This study aims to evaluate the adherence to a 4-week mobile health (mHealth) prescription to detect AF recurrences after an emergency department visit.Methods: After the emergency department visit, the 437 included patients, irrespective of randomisation arm (early or delayed cardioversion), were asked to record heart rate and rhythm for 1 min three times daily and in case of symptoms by an electrocardiography-based handheld device for 4 weeks (if available). Adherence was appraised as number of performed measurements per number of recordings asked from the patient and was evaluated for longitudinal adherence consistency. All patients who used the handheld device were included in this subanalysis.Results: 335 patients (58% males; median age 67 (IQR 11) years) were included. The median overall adherence of all patients was 83.3% (IQR 29.9%). The median number of monitoring days was 27 out of 27 (IQR 5), whereas the median number of full monitoring days was 16 out of 27 (IQR 14). Higher age and a previous paroxysm of AF were identified as multivariable adjusted factors associated with adherence.Conclusions: In this randomised trial, a 4-week mHealth prescription to monitor for AF recurrences after an emergency department visit for recent-onset AF was feasible with 85.7% of patients consistently using the device with at least one measurement per day. Older patients were more adherent.Trial Registration Number: NCT02248753. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

59. Corrigendum to 'Secondary Bjerknes Forces Deform Targeted Microbubbles' (Ultrasound Med Biol 2013;39:490–506) (Secondary Bjerknes Forces Deform Targeted Microbubbles (2013) 39(3) (490–506), (S0301562912006114), (10.1016/j.ultrasmedbio.2012.09.025))

Author

Kokhuis, Tom J. A., Garbin, Valeria, Kooiman, Klazina, Naaijkens, Benno A., Juffermans, Lynda J. M., Kamp, Otto, van der Steen, Antonius F. W., Versluis, Michel, de Jong, Nico, VU University medical center, Obstetrics and gynaecology, Cardiology, and ACS - Heart failure & arrhythmias

Abstract

The authors regret that there was a mistake in reporting the mol% of the microbubble coating composition used. For all experiments, the unit mg/mL was used, and the conversion mistake occurred only when converting to mol% to define the ratio between the coating formulation components. The correct molecular weight of PEG-40 stearate is 2046.54 g/mol (Shen et al. 2008; Kilic and Bolukcu 2018), not 328.53 g/mol. On page 494, the sentence should read “The coating was composed of 1,2-distearyol-sn-glycero-3-phosphocholine (84.8 mol%; P6517, Sigma-Aldrich, Zwijndrecht, The Netherlands); polyoxyethylene-40 stearate (8.2 mol%; P3440, Sigma-Aldrich); 1,2-distearyol-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)2000] (DSPE-PEG(2000); 5.9 mol%; 880125P, Avanti Polar Lipids, Alabaster, AL, USA); and DSPE-PEG(2000)-biotin (1.1 mol%; 880129C, Avanti Polar Lipids).” This correction does not change the conclusions published in this work. The authors apologize for any inconvenience caused.

Published
2021

60. Corrigendum for 'Intravital microscopy of localized stem cell delivery using microbubbles and acoustic radiation force' (Biotechnology and Bioengineering, (2015), 112, 1, (220-227), 10.1002/bit.25337)

Author

Kokhuis, Tom J. A., Skachkov, Ilya, Naaijkens, Benno A., Juffermans, Lynda J. M., Kamp, Otto, Kooiman, Klazina, van der Steen, Antonius F. W., Versluis, Michel, de Jong, Nico, VU University medical center, Obstetrics and gynaecology, Cardiology, and ACS - Heart failure & arrhythmias

Abstract

The authors regret that there was a mistake in calculating the mol% of the microbubble coating composition used. For all experiments the unit in mg/ml was utilized and the conversion mistake only came when converting to mol% to define the ratio between the coating formulation components. The correct molecular weight of PEG-40 stearate is 2046.54 g/mol (Kilic & Bolukcu, 2018; Shen et al., 2008), not 328.53 g/mol. On page 221, it should read “The coating was composed of DSPC (84.8 mol%; Sigma-Aldrich), PEG-40 stearate (8.2 mol%; Sigma-Aldrich), DSPE-PEG(2000) (5.9 mol%; Avanti Polar Lipids) and DSPE-PEG(2000)-biotin (1.1 mol%; Avanti Polar Lipids).” This correction does not change the conclusions published in this study. The authors would like to apologize for any inconvenience caused. The published article can be found here: https://onlinelibrary.wiley.com/doi/10.1002/bit.25337.

Published
2021

61. Corrigendum for 'Intravital microscopy of localized stem cell delivery using microbubbles and acoustic radiation force' (vol 112, pg 220-227, 2015)

Author

Kokhuis, Tom J. A., Skachkov, Ilya, Naaijkens, Benno A., Juffermans, Lynda J. M., Kamp, Otto, Kooiman, Klazina, van der Steen, Antonius F. W., Versluis, Michel, de Jong, Nico, Physics of Fluids, and TechMed Centre

Abstract

The authors regret that there was a mistake in calculating the mol% of the microbubble coating composition used. For all experiments the unit in mg/ml was utilized and the conversion mistake only came when converting to mol% to define the ratio between the coating formulation components. The correct molecular weight of PEG-40 stearate is 2046.54 g/mol (Kilic & Bolukcu, 2018; Shen et al., 2008), not 328.53 g/mol. On page 221, it should read “The coating was composed of DSPC (84.8 mol%; Sigma-Aldrich), PEG-40 stearate (8.2 mol%; Sigma-Aldrich), DSPE-PEG(2000) (5.9 mol%; Avanti Polar Lipids) and DSPE-PEG(2000)-biotin (1.1 mol%; Avanti Polar Lipids).” This correction does not change the conclusions published in this study. The authors would like to apologize for any inconvenience caused. The published article can be found here: https://onlinelibrary.wiley.com/doi/10.1002/bit.25337.

Published
2021

63. Microbubbles and Ultrasound Accelerated Thrombolysis for Peripheral Arterial Occlusions: The Outcomes of a Single Arm Phase II Trial

Author

Doelare, Sabrina A.N., primary, Jean Pierre, Dayanara M., additional, Nederhoed, Johanna H., additional, Smorenburg, Stefan P.M., additional, Lely, Rutger J., additional, Jongkind, Vincent, additional, Hoksbergen, Arjan W.J., additional, Ebben, Harm P., additional, Yeung, Kak K., additional, Wisselink, Willem, additional, van der Meijs, Bram B., additional, Meijerink, Martijn R., additional, Wiersema, Arno M., additional, Kievit, Jur, additional, Musters, René J.P., additional, Blankensteijn, Jan D., additional, Kamp, Otto, additional, and Slikkerveer, Jeroen, additional

Published
2021
Full Text
View/download PDF

69. Deterioration of pulmonary function: An early complication in Fibrodysplasia Ossificans Progressiva

Author

Botman, Esmée, primary, Smilde, Bernard J., additional, Hoebink, Max, additional, Treurniet, Sanne, additional, Raijmakers, Pieter, additional, Kamp, Otto, additional, Teunissen, Bernd P., additional, Bökenkamp, Arend, additional, Jak, Patrick, additional, Lammertsma, Adriaan A., additional, van den Aardweg, Joost G., additional, Boonstra, Anco, additional, and Eekhoff, Elisabeth M.W., additional

Published
2021
Full Text
View/download PDF

74. Lenient versus strict rate control in patients with atrial fibrillation

Author

Van Gelder, Isabelle C., Groenveld, Hessel F., Crijns, Harry J/G.M., Tuininga, Ype S., Tijssen, Jan G.P., Alings, A. Marco, Hillege, Hans L., Bergsma-Kadijk, Johanna A., Cornel, Jan H., Kamp, Otto, Tukkie, Raymond, Bosker, Hans A., Van Veldhuisen, Dirk J., and Van den Berg, Maarten

Subjects
Atrial fibrillation -- Health aspects, Cardiovascular diseases -- Care and treatment, Heart beat -- Measurement
Abstract

A study was conducted to evaluate and compare lenient rate control as against strict rate control as a form of treatment in patients with atrial fibrillation. Results indicated that in patients with permanent atrial fibrillation, both types of rate control were found to be equally effective with lenient rate control being easier to achieve.

Published
2010

75. Aspirin versus vitamin K antagonist treatment guided by transoesophageal echocardiography in patients with atrial fibrillation: a pilot study

Author

Dinh, Trang, Baur, Leo H B, Pisters, Ron, Kamp, Otto, Verheugt, Freek W A, Smeets, Joep L R M, Cheriex, Emile C, Lindeboom, Jan-Eize, Heesen, Wilfred F, Tieleman, Robert G, Prins, Martin H, Crijns, Harry J G M, Dinh, T, Pisters, R, Tieleman, RG, Prins, MH, Crijns, HJGM, Crijns, HJGM, Dinh, T, Baur, LHB, Kamp, O, Prins, MH, Verheugt, FWA, Pisters, R, Limburg, M, de Zwaan, C, ten Cate, H, and Lip, GY

Published
2014
Full Text
View/download PDF

79. Ankylosing Spondylitis Patients at Risk of Developing Aortic Valve Regurgitation, Need for Mandatory Echocardiography?

Author

Baniaamam, Milad, Heslinga, Sjoerd C., Boekel, Laura, Handoko, M. Louis, Konings, Thelma C., Kamp, Otto, van Halm, Vokko P., van Denderen, J. Christiaan, van der Horst-Bruinsma, Irene, Nurmohamed, Mike, Rheumatology, ACS - Atherosclerosis & ischemic syndromes, Cardiology, ACS - Heart failure & arrhythmias, APH - Personalized Medicine, ACS - Pulmonary hypertension & thrombosis, AII - Inflammatory diseases, AMS - Musculoskeletal Health, and AMS - Tissue Function & Regeneration

Published
2020

80. Identifying the as Patient at Risk: Is Aortic Root Diameter Associated with HLA-B27?

Author

Baniaamam, Milad, Heslinga, Sjoerd C., Handoko, M. Louis, Konings, Thelma C., Kamp, Otto, van Halm, Vokko P., van denderen, J. Christiaan, van der Horst-Bruinsma, Irene, Nurmohamed, Mike, Rheumatology, ACS - Atherosclerosis & ischemic syndromes, Cardiology, ACS - Heart failure & arrhythmias, APH - Personalized Medicine, ACS - Pulmonary hypertension & thrombosis, AII - Inflammatory diseases, AMS - Musculoskeletal Health, and AMS - Tissue Function & Regeneration

Published
2020

82. RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure: background, aims, and design of RACE II

Author

Van Gelder, Isabelle C., Van Veldhuisen, Dirk J., Crijns, J.G.M., Tuininga, Ype S., Tijssen, Jan G.P., Alings, A. Marco, Bosker, Hans A., Cornel, Jan H., Kamp, Otto, Veeger, Nic J.G.M., Volbeda, Meint, Rienstra, Michiel, Ranchor, Adelita V., TenVergert, Elisabeth M., and Van Den Berg, Maarten P.

Subjects
Atrial fibrillation -- Care and treatment, Atrial fibrillation -- Research, Atrial fibrillation -- Patient outcomes, Heart beat -- Research, Health
Published
2006

84. Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure: results from the RAte Control versus Electrical cardioversion (RACE) study

Author

Hagens, Vincent E., Crijns, Harry J.G.M., Van Veldhuisen, Dirk J., Van Den Berg, Maarten P., Rienstra, Michiel, Ranchor, Adelita V., Bosker, Hans A., Kamp, Otto, Tijssen, Jan G.P., Veeger, Nic J.G.M., and Van Gelder, Isabelle C.

Subjects
Atrial fibrillation -- Care and treatment, Atrial fibrillation -- Comparative analysis, Congestive heart failure -- Care and treatment, Congestive heart failure -- Comparative analysis, Quality of life -- Evaluation, Health
Published
2005

91. Automatic segmentation of echocardiographic sequences by active appearance motion models

Author

Bosch, Johan G., Mitchell, Steven C., Lelieveldt, Boudewijn P.F., Nijland, Francisca, Kamp, Otto, Sonka, Milan, and Reiber, Johan H.C.

Subjects
Echocardiography -- Evaluation, Heart -- Medical examination, Business, Electronics, Electronics and electrical industries, Health care industry
Abstract

A novel extension of active appearance models (AAMs) for automated border detection in echocardiographic image sequences is reported. The active appearance motion model (AAMM) technique allows fully automated robust and time-continuous delineation of left ventricular (LV) endocardial contours over the full heart cycle with good results. Nonlinear intensity normalization was developed and employed to accommodate ultrasound-specific intensity distributions. The method was trained and tested on 16-frame phase-normalized transthoracic four-chamber sequences of 129 unselected infarct patients, split randomly into a training set (n = 65) and a test set (n = 64). Borders were compared to expert drawn endocardial contours. On the test set, fully automated AAMM performed well in 97% of the cases (average distance between manual and automatic landmark points was 3.3 mm, comparable to human interobserver variabilities). The ultrasound-specific intensity normalization proved to be of great value for good results in echocardiograms. The AAMM was significantly more accurate than an equivalent set of two-dimensional AAMs. Index Terms--Active appearance models (AAMs), echocardiography, model-driven segmentation, time sequences.

Published
2002

99. EAE/ASE Recommendations for Image Acquisition and Display Using Three-Dimensional Echocardiography

Author

Lang, Roberto M., Badano, Luigi P., Tsang, Wendy, Adams, David H., Agricola, Eustachio, Buck, Thomas, Faletra, Francesco F., Franke, Andreas, Hung, Judy, de Isla, Leopoldo Pérez, Kamp, Otto, Kasprzak, Jaroslaw D., Lancellotti, Patrizio, Marwick, Thomas H., McCulloch, Marti L., Monaghan, Mark J., Nihoyannopoulos, Petros, Pandian, Natesa G., Pellikka, Patricia A., Pepi, Mauro, Roberson, David A., Shernan, Stanton K., Shirali, Girish S., Sugeng, Lissa, Ten Cate, Folkert J., Vannan, Mani A., Zamorano, Jose Luis, and Zoghbi, William A.

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results